ID
13952
Description
A randomised comparison of daily 25 mg versus 5 mg lenalidomide as maintenance therapy after high-dose therapy and autologous stem cell transplantation in patients with multiple myeloma. Protocol-Code: RV-MM-PI-280 EudraCT-Number: 2007-003945-33 Author: Claus Schreiber Review: Gerd Felder Approval of CRF: Prof. Dr. med. G. Kobbe (LKP) Release for MDM: Prof. Gattermann, Düsseldorf (26.1.2016) Principal Investigator „LenaMain“-Studie: Prof. Roland Fenk, Düsseldorf Coordinating center for clinical trial Medical faculty of University Hospital Heinrich-Heine-University Scientific Director: Herr Dr. J. Grebe Moorenstrasse 5 40225 Düsseldorf Tel.: +49 (0) 211-81-19701 Fax: +49 (0) 211-81-19702
Keywords
Versions (1)
- 3/17/16 3/17/16 -
Uploaded on
March 17, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Adverse events LenaMain-Study
Similar models
Adverse Events CTC
- StudyEvent: ODM
C0877248 (UMLS CUI [1,2])
C0008902 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C1705313 (UMLS CUI [1,2])
C2983704 (UMLS CUI [1,2])
C1705313 (UMLS CUI [1,3])
C0600091 (UMLS CUI [1,2])